Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel Disease - Summary - MDSpire

Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel Disease

  • By

  • Alexandre Mancheron

  • Agnès Dumas

  • Isabelle Nion Larmurier

  • Cecilia Landman

  • Laurent Peyrin Biroulet

  • Bénédicte Caron

  • Clotilde Baudry

  • Matthieu Allez

  • Mélanie Serrero

  • Dalal Yahioune

  • Stéphane Nancey

  • Céline Roman

  • Rémi Ducleau-Loras

  • Stéphanie Coopman

  • Priscilla Boizeau

  • Mathilde Husson

  • Shaya Sable

  • Iona Tarbet

  • Corinne Devos

  • Aurelie Bourmaud

  • Christine Martinez-Vinson

  • December 27, 2024

  • 0 min

Share

Objective:

To create and validate a sexual quality of life (QoL) score specifically for youth aged 15-25 with Inflammatory Bowel Disease (IBD), addressing the significant impact of IBD on sexual health.

Key Findings:
  • BLOOMI is a 10-item sexual QoL score that correlates well with established gold standards, indicating its reliability.
  • 19.1% of IIEF-responders reported erectile dysfunction, highlighting a significant concern in this population.
  • Median scores for SFQ domains related to sexual function were below the threshold for normal sexual function, suggesting widespread issues.
  • Factors like fatigue, abdominal pain, and body image concerns negatively impacted sexual QoL, underscoring the need for holistic care.
Interpretation:

BLOOMI provides a reliable tool for assessing sexual QoL in young IBD patients, emphasizing the need for improved discussions around sexuality in clinical settings to enhance patient care.

Limitations:
  • The study's sample size was limited to 104 participants, which may affect the robustness of the findings.
  • The focus was solely on French-speaking populations, which may limit generalizability to other demographics.
Conclusion:

BLOOMI is a validated tool that can enhance the understanding and management of sexual health issues in young individuals with IBD, facilitating better clinical conversations and highlighting the need for further research in diverse populations.

Original Source(s)

Related Content